Pfizer (PFE) Other Non-Current Assets (2016 - 2025)
Pfizer (PFE) has disclosed Other Non-Current Assets for 17 consecutive years, with $9.6 billion as the latest value for Q4 2025.
- Quarterly Other Non-Current Assets fell 1.89% to $9.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.6 billion through Dec 2025, down 1.89% year-over-year, with the annual reading at $9.6 billion for FY2025, 1.89% down from the prior year.
- Other Non-Current Assets for Q4 2025 was $9.6 billion at Pfizer, up from $9.3 billion in the prior quarter.
- The five-year high for Other Non-Current Assets was $13.2 billion in Q4 2022, with the low at $4.7 billion in Q2 2021.
- Average Other Non-Current Assets over 5 years is $9.6 billion, with a median of $9.7 billion recorded in 2024.
- The sharpest move saw Other Non-Current Assets skyrocketed 71.42% in 2022, then fell 21.28% in 2024.
- Over 5 years, Other Non-Current Assets stood at $7.7 billion in 2021, then soared by 71.42% to $13.2 billion in 2022, then dropped by 5.26% to $12.5 billion in 2023, then decreased by 21.28% to $9.8 billion in 2024, then decreased by 1.89% to $9.6 billion in 2025.
- According to Business Quant data, Other Non-Current Assets over the past three periods came in at $9.6 billion, $9.3 billion, and $9.5 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.